Texas Roadhouse earnings missed by $0.05, revenue topped estimates
On Tuesday, Wedbush Securities reaffirmed its confidence in Beyond Inc. (NYSE:BYON), maintaining an Outperform rating and a $15.00 price target for the company’s stock, significantly above the current price of $4.02. According to InvestingPro data, analyst targets range from $6.50 to $16.00, with 4 analysts recently revising their earnings estimates upward. The firm’s stance comes as Beyond continues to navigate through a period of restructuring following its rebranding from Overstock.com . Wedbush believes that Beyond’s efforts to reduce fixed costs, enhance profitability, and expand its business will significantly benefit shareholders in the coming years.
Beyond has been focusing on its turnaround for over a year, implementing substantial changes to correct previous missteps. The company’s journey toward value creation has been marked by revenue declines of 10.64% and substantial losses in 2024, with InvestingPro data showing a concerning negative EBITDA of $183.26 million as it dealt with the aftermath of rebranding and the elimination of unproductive stock keeping units (SKUs). Despite these challenges, the company maintains a healthy balance sheet with more cash than debt. Despite these challenges and recent adjustments to its assets and brand, analysts at Wedbush are optimistic about Beyond’s trajectory toward profitable growth.
The company’s strategic initiatives are expected to drive revenue growth substantially higher than current projections. Nevertheless, Wedbush adopts a cautious approach, citing past quarters of underperformance as a reason for conservatism. Beyond may face pricing challenges due to sourcing from China, but the overall strategy is considered to be robust.
Beyond Inc. is anticipated to capitalize on its investment in buybuy Baby in the near future, and to gain momentum from the relaunch of Overstock.com and its partnership with Kirkland’s (NASDAQ:KIRK). The company has also shown optimism regarding its Medici portfolio, with potential contributions from tZERO and GrainChain in the next few years.
Despite the ongoing impact of tariffs creating uncertainty, Wedbush is confident in Beyond’s management and their strategy. The firm expects the company to achieve success through expanding gross margins, currently at 20.8%, and reducing operating expenses. The reiterated $15 price target by Wedbush reflects a valuation of 0.23 times the firm’s 2027 revenue estimate, with an additional approximate value of $3 for the Medici assets. InvestingPro analysis suggests the stock is currently undervalued, with 12 additional ProTips and comprehensive financial metrics available to subscribers, including detailed valuation models and peer comparison tools. Discover the full potential of your investment decisions with InvestingPro’s in-depth research reports, available for over 1,400 US stocks.
In other recent news, Beyond, Inc. has made significant announcements impacting its operations and future strategies. The company has sold a majority stake in its Zulily brand to Lyons Trading Company for $5 million, retaining a 25% interest to focus on its core brands like Bed Bath & Beyond and Overstock. This move aligns with Beyond’s strategic efforts to optimize resources and improve profitability. Additionally, Beyond has appointed Debra Perelman, former CEO of Revlon, as an independent director to its Board, bringing her extensive experience in the digital and consumer sectors to the company.
In terms of leadership changes, Marcus Lemonis has been appointed as the Principal Executive Officer and Adrianne Lee as President & CFO, with a focus on returning the company to profitability through strategic priorities and cost reductions. Beyond has announced an additional $15 million in fixed cost reductions as part of its ongoing efforts to improve financial performance. Analyst reactions have been mixed; Jefferies adjusted its price target for Beyond to $6.50, maintaining a Hold rating, while Needham downgraded the stock from Buy to Hold due to concerns about revenue projections and the extended timeline for achieving adjusted EBITDA positivity.
These developments reflect Beyond’s continued efforts to navigate financial challenges and enhance its market position. The company’s cash position, representing approximately 70% of its market capitalization, remains a point of interest for analysts. As Beyond, Inc. continues its strategic realignment, the market is closely monitoring these changes and their potential impact on the company’s financial trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.